Oxford Immunotec Appoints Chief Financial Officer

Oxford, UK; 10 October 2005 – Oxford Immunotec Ltd. announced today the appointment of Mr Ian Miscampbell as Chief Financial Officer (CFO) with immediate effect.

Mr. Miscampbell has over 15 years experience in senior financial positions and joins Oxford Immunotec from Microscience Holdings Plc, where he was Finance Director. Previously, Mr. Miscampbell was Chief Operating Officer and Finance Director of KS Biomedix Holdings plc and before that Finance Director of Reneuron Limited. Before entering the life sciences sector he gained significant experience as Finance Director in medium sized entities in the textiles and food sectors, having previously qualified as a Chartered Accountant with KPMG. Mr. Miscampbell will replace Mr. Iain Rae, who held the position part-time.

Dr. Peter Wrighton-Smith, Oxford Immunotec’s Chief Executive Officer, said, “We are delighted to have Ian join our management team at this time in the company’s development. Ian has a proven track record of strategy development, M&A and operations in life sciences companies, as well as significant experience of fundraising in both the private and public markets. Ian will be a key member of the management team, to continue the company’s success. I would also like to take this opportunity to thank Iain Rae for his support and commitment throughout his time with the company.”

Mr. Miscampbell, Oxford Immunotec’s new CFO, commented, “I am delighted to be joining Oxford Immunotec at this exciting time. I look forward to playing a key role in the worldwide expansion of T-SPOT.TBand in driving acceptance of the Company’s innovative technology as a completely new method of diagnosis and monitoring of disease.”